Insulet Corp Enters Material Agreement, Takes on New Financial Obligation

TL;DR

**Insulet just took on a new financial obligation and entered a material agreement, details pending.**

AI Summary

Insulet Corporation, a medical device company, filed an 8-K on January 25, 2024, reporting an "Entry into a Material Definitive Agreement" and the "Creation of a Direct Financial Obligation" on January 24, 2024. This indicates the company has entered into a significant new contract or taken on new debt, which could impact its financial health and future operations. Investors should pay close attention to the details of this agreement, as it could affect Insulet's profitability and growth prospects.

Why It Matters

This filing signals a potentially significant change in Insulet's financial structure or operational commitments, which could impact its future earnings and stock valuation. Understanding the nature of this agreement is crucial for assessing the company's risk and growth potential.

Risk Assessment

Risk Level: medium — The filing indicates a new financial obligation and material agreement without providing specific details, creating uncertainty about its potential positive or negative impact.

Analyst Insight

A smart investor would await further details on the "Material Definitive Agreement" and "Direct Financial Obligation" to understand their nature, size, and potential impact on Insulet's balance sheet and future profitability before making any investment decisions.

Key Players & Entities

• INSULET CORP (company) — the registrant filing the 8-K
• January 24, 2024 (date) — date of the earliest event reported
• January 25, 2024 (date) — date the 8-K was filed
• 001-33462 (dollar_amount) — Commission File Number
• 100 Nagog Park, Acton, MA 01720 (company) — business address of Insulet Corporation
• 978-600-7000 (dollar_amount) — registrant's telephone number

FAQ

From the Filing

0001193125-24-014842.txt : 20240125 0001193125-24-014842.hdr.sgml : 20240125 20240125071931 ACCESSION NUMBER: 0001193125-24-014842 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240124 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240125 DATE AS OF CHANGE: 20240125 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INSULET CORP CENTRAL INDEX KEY: 0001145197 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 043523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33462 FILM NUMBER: 24558569 BUSINESS ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-600-7000 MAIL ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 8-K 1 d730170d8k.htm FORM 8-K Form 8-K INSULET CORP false 0001145197 0001145197 2024-01-24 2024-01-24     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 24, 2024     INSULET CORPORATION (Exact name of registrant as specified in its charter)       Delaware   001-33462   04-3523891 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) 100 Nagog Park , Acton , MA   01720 (Address of principal executive offices)   (Zip Code) Registrant’s telephone number, including area code: (978) 600-7000 Not Applicable (Former name or former address, if changed since last report)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, $0.001 Par Value Per Share   PODD   The NASDAQ Stock Market, LLC       Item 1.01 Entry into a Material Definitive Agreement. On January 24, 2024, Insulet Corporation (the “ Company ”) entered into the Fifth Amendment to Credit Agreement (the “ Amendment ”) with the lenders and other parties thereto and Morgan Stanley Senior Funding, Inc., as administrative agent (the “ Agent ”), amending that certain Credit Agreement, dated as of May 4, 2021 (as previously amended, supplemented or modified, the &#8220